GB2341606A - Glycosylation peptides - Google Patents

Glycosylation peptides

Info

Publication number
GB2341606A
GB2341606A GB9930098A GB9930098A GB2341606A GB 2341606 A GB2341606 A GB 2341606A GB 9930098 A GB9930098 A GB 9930098A GB 9930098 A GB9930098 A GB 9930098A GB 2341606 A GB2341606 A GB 2341606A
Authority
GB
United Kingdom
Prior art keywords
sequence
glycosylation
encodes
fragment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9930098A
Other versions
GB9930098D0 (en
Inventor
Robert Glynn Hewinson
Stephen Lloyd Michell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minister of Agriculture Fisheries and Food UK
Original Assignee
Minister of Agriculture Fisheries and Food UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minister of Agriculture Fisheries and Food UK filed Critical Minister of Agriculture Fisheries and Food UK
Publication of GB9930098D0 publication Critical patent/GB9930098D0/en
Publication of GB2341606A publication Critical patent/GB2341606A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A recombinant DNA which encodes a polypeptide which is other than a wild-type or native polypeptide and which is glycosylated when expressed in an actinomycete host, said DNA comprising a sequence which encodes the amino acid sequence: PAAPVTTAA (SEQ ID NO. 1) or a fragment or variant thereof; said fragment or variant including at least both the threonine residues and being able to act as a glycosylation motif; and/or a sequence which encodes a glycosylation motif found in the region of the MPT83 protein including asparagine at position 192 in the sequence, such as the sequence: DLTVIGARDDLMVNNAGL (SEQ ID NO. 3) or a fragment thereof. These recombinant DNA are useful in the production of vaccines, since, they can provide a glycosylation site, recognised in particular by actinomycetes. Glycosylation is preferred as this may improve immunogenicity and stability of an immunogenic protein.
GB9930098A 1997-07-07 1998-07-06 Glycosylation peptides Withdrawn GB2341606A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714242.6A GB9714242D0 (en) 1997-07-07 1997-07-07 Glycosylation peptides
PCT/GB1998/001989 WO1999002706A1 (en) 1997-07-07 1998-07-06 Glycosylation peptides

Publications (2)

Publication Number Publication Date
GB9930098D0 GB9930098D0 (en) 2000-02-09
GB2341606A true GB2341606A (en) 2000-03-22

Family

ID=10815445

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9714242.6A Ceased GB9714242D0 (en) 1997-07-07 1997-07-07 Glycosylation peptides
GB9930098A Withdrawn GB2341606A (en) 1997-07-07 1998-07-06 Glycosylation peptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9714242.6A Ceased GB9714242D0 (en) 1997-07-07 1997-07-07 Glycosylation peptides

Country Status (3)

Country Link
AU (1) AU8231998A (en)
GB (2) GB9714242D0 (en)
WO (1) WO1999002706A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014823A1 (en) * 1991-02-14 1992-09-03 N.V. Innogenetics S.A. Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
WO1994005780A1 (en) * 1992-08-28 1994-03-17 The Public Health Research Institute Of The City Of New York, Inc. Fusion glycoproteins
WO1997008322A1 (en) * 1995-08-25 1997-03-06 The Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Mpt83 gene from mycobacterium tuberculosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014823A1 (en) * 1991-02-14 1992-09-03 N.V. Innogenetics S.A. Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
WO1994005780A1 (en) * 1992-08-28 1994-03-17 The Public Health Research Institute Of The City Of New York, Inc. Fusion glycoproteins
WO1997008322A1 (en) * 1995-08-25 1997-03-06 The Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Mpt83 gene from mycobacterium tuberculosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Pharmaceutical Research Vol. 10, No. 9, 1 September 1993, pages 1268-1273, Powell et al. *

Also Published As

Publication number Publication date
AU8231998A (en) 1999-02-08
WO1999002706A1 (en) 1999-01-21
GB9714242D0 (en) 1997-09-10
GB9930098D0 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
DE69829668D1 (en) PREPARATION AND USE OF RECOMBINANT INFLUENZA A VIRUS M2 CONSTRUCTIONS AND IMPORTS
CA2032153A1 (en) Application of new dna fragments as sequence coding for a signal peptide for the secretion of mature proteins by recombinant yeasts, expression cassettes, processed yeasts and corresponding protein preparation process.
KR880007734A (en) Polypeptide derivatives
BR0015137A (en) Neisserial antigenic peptides
KR870009025A (en) Aprotinin homologues prepared from recombinant hosts, methods thereof, expression vectors and recombinant hosts and pharmacological uses thereof
RU2003103779A (en) EXPRESSION SYSTEM
NZ331829A (en) Clostridium perfringens vaccines
RU2225220C1 (en) Fused protein eliciting in vivo enhanced activity of erythropoietin
BRPI0412799A (en) immunogen, composition, nucleic acid, recombinant cell, methods for preparing a polypeptide, for inducing a protective immune response in a patient and for inducing an anamnesic response in a patient, and optimized yeast nucleic acid sequence
TW200716166A (en) Lawsonia intracellularis immunological proteins
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
AU5776799A (en) Modified hcv peptide vaccines
EP1512693A3 (en) Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
CA2450548A1 (en) Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
EP0342173A3 (en) Fibronectin binding protein as well as its preparation
GB2341606A (en) Glycosylation peptides
CA2253006A1 (en) .beta.-carotene hydroxylase gene
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
EP0887410A3 (en) DNA encoding a plasminogen activating protein
NO20011263D0 (en) Moraxella Catarrhalis BASBO34 polypeptides and uses thereof
CA2642146A1 (en) Xrec2 dnas and polypeptides
DE60036676D1 (en) G-PROTEIN-COUPLED RECEPTOR-SIMILAR PROTEINS
EP0845536A3 (en) Protein having ethylenediamine-N,N'-disuccinic acid: ethylenediamine lyase activity and gene encoding the same
WO2003022867A3 (en) Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
EP0897984A3 (en) D-Sorbitol dehydrogenase gene

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)